nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—NR3C2—collecting duct of renal tubule—nephrolithiasis	0.059	0.122	CbGeAlD
Dexamethasone—PLA2G1B—nephron—nephrolithiasis	0.053	0.11	CbGeAlD
Dexamethasone—Erythema facial—Hydrochlorothiazide—nephrolithiasis	0.0449	0.122	CcSEcCtD
Dexamethasone—NR3C2—nephron—nephrolithiasis	0.0263	0.0543	CbGeAlD
Dexamethasone—Electrolyte imbalance—Hydrochlorothiazide—nephrolithiasis	0.0196	0.0534	CcSEcCtD
Dexamethasone—Intraocular pressure increased—Hydrochlorothiazide—nephrolithiasis	0.0186	0.0507	CcSEcCtD
Dexamethasone—Trauma—Hydrochlorothiazide—nephrolithiasis	0.0172	0.0468	CcSEcCtD
Dexamethasone—CYP2C19—urine—nephrolithiasis	0.0145	0.0299	CbGeAlD
Dexamethasone—CYP4A11—renal system—nephrolithiasis	0.0126	0.026	CbGeAlD
Dexamethasone—Peptic ulcer—Hydrochlorothiazide—nephrolithiasis	0.0123	0.0334	CcSEcCtD
Dexamethasone—PTGS2—nephron—nephrolithiasis	0.0122	0.0252	CbGeAlD
Dexamethasone—CYP4A11—kidney—nephrolithiasis	0.0121	0.0251	CbGeAlD
Dexamethasone—CYP4A11—cortex of kidney—nephrolithiasis	0.0118	0.0245	CbGeAlD
Dexamethasone—NR3C1—urine—nephrolithiasis	0.0113	0.0234	CbGeAlD
Dexamethasone—CYP2C9—urine—nephrolithiasis	0.0112	0.0232	CbGeAlD
Dexamethasone—CYP2E1—urine—nephrolithiasis	0.0106	0.022	CbGeAlD
Dexamethasone—PLA2G1B—renal system—nephrolithiasis	0.0104	0.0215	CbGeAlD
Dexamethasone—Stinging—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0275	CcSEcCtD
Dexamethasone—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0275	CcSEcCtD
Dexamethasone—PLA2G1B—kidney—nephrolithiasis	0.0101	0.0208	CbGeAlD
Dexamethasone—ANXA1—nephron tubule—nephrolithiasis	0.00876	0.0181	CbGeAlD
Dexamethasone—CYP3A4—urine—nephrolithiasis	0.00855	0.0177	CbGeAlD
Dexamethasone—CYP2D6—urine—nephrolithiasis	0.00841	0.0174	CbGeAlD
Dexamethasone—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.0084	0.0229	CcSEcCtD
Dexamethasone—ANXA1—renal system—nephrolithiasis	0.00796	0.0165	CbGeAlD
Dexamethasone—CYP17A1—nephron tubule—nephrolithiasis	0.00785	0.0162	CbGeAlD
Dexamethasone—ANXA1—kidney—nephrolithiasis	0.0077	0.0159	CbGeAlD
Dexamethasone—ANXA1—cortex of kidney—nephrolithiasis	0.00749	0.0155	CbGeAlD
Dexamethasone—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.00749	0.0204	CcSEcCtD
Dexamethasone—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.00741	0.0202	CcSEcCtD
Dexamethasone—CYP3A7-CYP3A51P—nephron tubule—nephrolithiasis	0.00741	0.0153	CbGeAlD
Dexamethasone—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.00729	0.0199	CcSEcCtD
Dexamethasone—CYP17A1—renal system—nephrolithiasis	0.00713	0.0148	CbGeAlD
Dexamethasone—CYP17A1—kidney—nephrolithiasis	0.0069	0.0143	CbGeAlD
Dexamethasone—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00684	0.0186	CcSEcCtD
Dexamethasone—CYP17A1—cortex of kidney—nephrolithiasis	0.00672	0.0139	CbGeAlD
Dexamethasone—Injury—Hydrochlorothiazide—nephrolithiasis	0.00647	0.0176	CcSEcCtD
Dexamethasone—CYP3A7-CYP3A51P—cortex of kidney—nephrolithiasis	0.00634	0.0131	CbGeAlD
Dexamethasone—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.00633	0.0172	CcSEcCtD
Dexamethasone—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.00628	0.0171	CcSEcCtD
Dexamethasone—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00585	0.0159	CcSEcCtD
Dexamethasone—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00585	0.0159	CcSEcCtD
Dexamethasone—NR3C2—nephron tubule—nephrolithiasis	0.00567	0.0117	CbGeAlD
Dexamethasone—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00563	0.0153	CcSEcCtD
Dexamethasone—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00545	0.0148	CcSEcCtD
Dexamethasone—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00541	0.0147	CcSEcCtD
Dexamethasone—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00525	0.0143	CcSEcCtD
Dexamethasone—NR3C2—renal system—nephrolithiasis	0.00515	0.0107	CbGeAlD
Dexamethasone—NR3C2—kidney—nephrolithiasis	0.00498	0.0103	CbGeAlD
Dexamethasone—NR3C2—cortex of kidney—nephrolithiasis	0.00485	0.01	CbGeAlD
Dexamethasone—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00468	0.0127	CcSEcCtD
Dexamethasone—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00464	0.0126	CcSEcCtD
Dexamethasone—ABCC2—nephron tubule—nephrolithiasis	0.00453	0.00937	CbGeAlD
Dexamethasone—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00452	0.0123	CcSEcCtD
Dexamethasone—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00449	0.0122	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00449	0.0122	CcSEcCtD
Dexamethasone—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00446	0.0121	CcSEcCtD
Dexamethasone—CYP1B1—nephron tubule—nephrolithiasis	0.00443	0.00918	CbGeAlD
Dexamethasone—SLCO1A2—renal system—nephrolithiasis	0.00442	0.00914	CbGeAlD
Dexamethasone—SLCO1A2—kidney—nephrolithiasis	0.00427	0.00884	CbGeAlD
Dexamethasone—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00419	0.0114	CcSEcCtD
Dexamethasone—ABCC2—renal system—nephrolithiasis	0.00412	0.00852	CbGeAlD
Dexamethasone—CYP1B1—renal system—nephrolithiasis	0.00403	0.00834	CbGeAlD
Dexamethasone—ABCC2—kidney—nephrolithiasis	0.00398	0.00823	CbGeAlD
Dexamethasone—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00397	0.0108	CcSEcCtD
Dexamethasone—CYP1B1—kidney—nephrolithiasis	0.0039	0.00806	CbGeAlD
Dexamethasone—ABCC2—cortex of kidney—nephrolithiasis	0.00388	0.00802	CbGeAlD
Dexamethasone—CYP1B1—cortex of kidney—nephrolithiasis	0.0038	0.00785	CbGeAlD
Dexamethasone—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00368	0.01	CcSEcCtD
Dexamethasone—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00364	0.0099	CcSEcCtD
Dexamethasone—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00358	0.00975	CcSEcCtD
Dexamethasone—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00332	0.00905	CcSEcCtD
Dexamethasone—ABCG2—nephron tubule—nephrolithiasis	0.0033	0.00683	CbGeAlD
Dexamethasone—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00327	0.00891	CcSEcCtD
Dexamethasone—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00323	0.00879	CcSEcCtD
Dexamethasone—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00322	0.00876	CcSEcCtD
Dexamethasone—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00321	0.00874	CcSEcCtD
Dexamethasone—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00315	0.00857	CcSEcCtD
Dexamethasone—CYP2C8—renal system—nephrolithiasis	0.00309	0.00639	CbGeAlD
Dexamethasone—CYP3A5—nephron tubule—nephrolithiasis	0.00307	0.00634	CbGeAlD
Dexamethasone—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00305	0.0083	CcSEcCtD
Dexamethasone—CYP2B6—nephron tubule—nephrolithiasis	0.00305	0.0063	CbGeAlD
Dexamethasone—NR3C1—nephron tubule—nephrolithiasis	0.00304	0.00629	CbGeAlD
Dexamethasone—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00304	0.00827	CcSEcCtD
Dexamethasone—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00301	0.0082	CcSEcCtD
Dexamethasone—CYP2C8—kidney—nephrolithiasis	0.00298	0.00618	CbGeAlD
Dexamethasone—CYP3A43—Biological oxidations—SLC26A1—nephrolithiasis	0.00295	0.0198	CbGpPWpGaD
Dexamethasone—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00292	0.00796	CcSEcCtD
Dexamethasone—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00292	0.00796	CcSEcCtD
Dexamethasone—Shock—Hydrochlorothiazide—nephrolithiasis	0.00288	0.00783	CcSEcCtD
Dexamethasone—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00286	0.00779	CcSEcCtD
Dexamethasone—CYP2E1—nephron tubule—nephrolithiasis	0.00286	0.00592	CbGeAlD
Dexamethasone—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00285	0.00777	CcSEcCtD
Dexamethasone—CYP1A1—renal system—nephrolithiasis	0.00285	0.0059	CbGeAlD
Dexamethasone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00285	0.0191	CbGpPWpGaD
Dexamethasone—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00283	0.00769	CcSEcCtD
Dexamethasone—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00279	0.00758	CcSEcCtD
Dexamethasone—CYP3A5—renal system—nephrolithiasis	0.00279	0.00577	CbGeAlD
Dexamethasone—NOS2—Spinal Cord Injury—AQP1—nephrolithiasis	0.00277	0.0186	CbGpPWpGaD
Dexamethasone—CYP2B6—renal system—nephrolithiasis	0.00277	0.00573	CbGeAlD
Dexamethasone—NR3C1—renal system—nephrolithiasis	0.00276	0.00572	CbGeAlD
Dexamethasone—CYP1A1—kidney—nephrolithiasis	0.00275	0.0057	CbGeAlD
Dexamethasone—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00273	0.00744	CcSEcCtD
Dexamethasone—CYP3A5—kidney—nephrolithiasis	0.00269	0.00557	CbGeAlD
Dexamethasone—CYP2B6—kidney—nephrolithiasis	0.00268	0.00554	CbGeAlD
Dexamethasone—NR3C1—kidney—nephrolithiasis	0.00267	0.00553	CbGeAlD
Dexamethasone—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00266	0.00725	CcSEcCtD
Dexamethasone—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00264	0.0072	CcSEcCtD
Dexamethasone—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00263	0.00715	CcSEcCtD
Dexamethasone—CYP3A5—cortex of kidney—nephrolithiasis	0.00262	0.00543	CbGeAlD
Dexamethasone—NR3C1—cortex of kidney—nephrolithiasis	0.0026	0.00539	CbGeAlD
Dexamethasone—CYP2E1—renal system—nephrolithiasis	0.0026	0.00538	CbGeAlD
Dexamethasone—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00257	0.007	CcSEcCtD
Dexamethasone—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00254	0.00692	CcSEcCtD
Dexamethasone—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00252	0.00686	CcSEcCtD
Dexamethasone—CYP2E1—kidney—nephrolithiasis	0.00251	0.0052	CbGeAlD
Dexamethasone—Pain—Hydrochlorothiazide—nephrolithiasis	0.0025	0.0068	CcSEcCtD
Dexamethasone—CYP2E1—cortex of kidney—nephrolithiasis	0.00245	0.00506	CbGeAlD
Dexamethasone—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00241	0.00656	CcSEcCtD
Dexamethasone—PTGS2—renal system—nephrolithiasis	0.00239	0.00495	CbGeAlD
Dexamethasone—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00239	0.00651	CcSEcCtD
Dexamethasone—CYP4A11—NRF2 pathway—SLC2A9—nephrolithiasis	0.00233	0.0156	CbGpPWpGaD
Dexamethasone—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00232	0.00632	CcSEcCtD
Dexamethasone—PTGS2—kidney—nephrolithiasis	0.00231	0.00479	CbGeAlD
Dexamethasone—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00231	0.00629	CcSEcCtD
Dexamethasone—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00231	0.00629	CcSEcCtD
Dexamethasone—ANXA1—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.0023	0.0154	CbGpPWpGaD
Dexamethasone—CYP17A1—Biological oxidations—SLC26A1—nephrolithiasis	0.00226	0.0151	CbGpPWpGaD
Dexamethasone—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.0021	0.00571	CcSEcCtD
Dexamethasone—CYP3A4—renal system—nephrolithiasis	0.00209	0.00433	CbGeAlD
Dexamethasone—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00207	0.00563	CcSEcCtD
Dexamethasone—CYP11A1—Biological oxidations—SLC26A1—nephrolithiasis	0.00207	0.0138	CbGpPWpGaD
Dexamethasone—CYP2D6—renal system—nephrolithiasis	0.00206	0.00426	CbGeAlD
Dexamethasone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00206	0.0138	CbGpPWpGaD
Dexamethasone—CYP4A11—Biological oxidations—SLC26A1—nephrolithiasis	0.00204	0.0137	CbGpPWpGaD
Dexamethasone—CYP3A4—kidney—nephrolithiasis	0.00202	0.00418	CbGeAlD
Dexamethasone—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.002	0.00544	CcSEcCtD
Dexamethasone—CYP2D6—kidney—nephrolithiasis	0.00199	0.00412	CbGeAlD
Dexamethasone—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00193	0.00526	CcSEcCtD
Dexamethasone—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00186	0.00506	CcSEcCtD
Dexamethasone—Rash—Hydrochlorothiazide—nephrolithiasis	0.00184	0.00502	CcSEcCtD
Dexamethasone—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00184	0.00501	CcSEcCtD
Dexamethasone—Headache—Hydrochlorothiazide—nephrolithiasis	0.00183	0.00498	CcSEcCtD
Dexamethasone—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00174	0.00473	CcSEcCtD
Dexamethasone—SLCO1A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00169	0.0113	CbGpPWpGaD
Dexamethasone—ABCB1—nephron tubule—nephrolithiasis	0.00163	0.00337	CbGeAlD
Dexamethasone—ABCC2—NRF2 pathway—SLC2A9—nephrolithiasis	0.00157	0.0105	CbGpPWpGaD
Dexamethasone—SLCO1A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00154	0.0103	CbGpPWpGaD
Dexamethasone—SLCO1A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00154	0.0103	CbGpPWpGaD
Dexamethasone—ANXA1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00152	0.0102	CbGpPWpGaD
Dexamethasone—ABCB1—renal system—nephrolithiasis	0.00148	0.00306	CbGeAlD
Dexamethasone—ABCB1—kidney—nephrolithiasis	0.00143	0.00296	CbGeAlD
Dexamethasone—ABCB1—cortex of kidney—nephrolithiasis	0.00139	0.00288	CbGeAlD
Dexamethasone—CYP19A1—Biological oxidations—SLC26A1—nephrolithiasis	0.00137	0.00916	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00134	0.00899	CbGpPWpGaD
Dexamethasone—CYP1B1—Biological oxidations—SLC26A1—nephrolithiasis	0.00132	0.00882	CbGpPWpGaD
Dexamethasone—CYP2A6—NRF2 pathway—SLC2A9—nephrolithiasis	0.00124	0.00831	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—RGS14—nephrolithiasis	0.00122	0.00816	CbGpPWpGaD
Dexamethasone—CYP3A7—Biological oxidations—SLC26A1—nephrolithiasis	0.00119	0.00796	CbGpPWpGaD
Dexamethasone—SLCO1A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00117	0.00783	CbGpPWpGaD
Dexamethasone—SLCO1A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00117	0.00783	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00116	0.00777	CbGpPWpGaD
Dexamethasone—CYP2A6—Biological oxidations—SLC26A1—nephrolithiasis	0.00109	0.00729	CbGpPWpGaD
Dexamethasone—SLCO1A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00109	0.00728	CbGpPWpGaD
Dexamethasone—SLCO1A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00109	0.00728	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—DGKH—nephrolithiasis	0.00108	0.00725	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—SLC7A9—nephrolithiasis	0.00108	0.00725	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR ligand binding—PTH—nephrolithiasis	0.00106	0.00711	CbGpPWpGaD
Dexamethasone—SLCO1A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00097	0.00649	CbGpPWpGaD
Dexamethasone—SLCO1A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000962	0.00644	CbGpPWpGaD
Dexamethasone—SLCO1A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000962	0.00644	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000907	0.00607	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—AQP1—nephrolithiasis	0.000881	0.0059	CbGpPWpGaD
Dexamethasone—CYP2B6—Biological oxidations—SLC26A1—nephrolithiasis	0.000879	0.00588	CbGpPWpGaD
Dexamethasone—ABCC2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000876	0.00587	CbGpPWpGaD
Dexamethasone—ABCC2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000876	0.00587	CbGpPWpGaD
Dexamethasone—CYP2E1—Biological oxidations—SLC26A1—nephrolithiasis	0.000861	0.00576	CbGpPWpGaD
Dexamethasone—CYP3A5—Biological oxidations—SLC26A1—nephrolithiasis	0.000859	0.00575	CbGpPWpGaD
Dexamethasone—SLCO1A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000858	0.00574	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—ADCY10—nephrolithiasis	0.000847	0.00567	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—GRHPR—nephrolithiasis	0.000845	0.00566	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—DGKH—nephrolithiasis	0.000824	0.00551	CbGpPWpGaD
Dexamethasone—CYP1A1—Biological oxidations—SLC26A1—nephrolithiasis	0.000811	0.00543	CbGpPWpGaD
Dexamethasone—SLCO1A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000785	0.00525	CbGpPWpGaD
Dexamethasone—SLCO1A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000785	0.00525	CbGpPWpGaD
Dexamethasone—ABCC2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000781	0.00523	CbGpPWpGaD
Dexamethasone—ABCG2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000762	0.0051	CbGpPWpGaD
Dexamethasone—ABCG2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000762	0.0051	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—AGXT—nephrolithiasis	0.000754	0.00505	CbGpPWpGaD
Dexamethasone—CYP2C8—Biological oxidations—SLC26A1—nephrolithiasis	0.000744	0.00498	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—RGS14—nephrolithiasis	0.00072	0.00482	CbGpPWpGaD
Dexamethasone—ABCC2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000714	0.00478	CbGpPWpGaD
Dexamethasone—ABCC2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000714	0.00478	CbGpPWpGaD
Dexamethasone—ABCG2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000679	0.00455	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—GRHPR—nephrolithiasis	0.000666	0.00446	CbGpPWpGaD
Dexamethasone—CYP2C19—Biological oxidations—SLC26A1—nephrolithiasis	0.000664	0.00445	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000656	0.00439	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—SLC26A1—nephrolithiasis	0.000641	0.00429	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—APRT—nephrolithiasis	0.000641	0.00429	CbGpPWpGaD
Dexamethasone—ABCG2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000621	0.00416	CbGpPWpGaD
Dexamethasone—ABCG2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000621	0.00416	CbGpPWpGaD
Dexamethasone—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.000611	0.00409	CbGpPWpGaD
Dexamethasone—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.000605	0.00405	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—PTH—nephrolithiasis	0.0006	0.00402	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000595	0.00399	CbGpPWpGaD
Dexamethasone—SLCO1A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000595	0.00398	CbGpPWpGaD
Dexamethasone—SLCO1A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000595	0.00398	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—AGXT—nephrolithiasis	0.000593	0.00397	CbGpPWpGaD
Dexamethasone—NOS2—Disease—SLC26A1—nephrolithiasis	0.000588	0.00394	CbGpPWpGaD
Dexamethasone—SLCO1A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000553	0.0037	CbGpPWpGaD
Dexamethasone—SLCO1A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000553	0.0037	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—PTH—nephrolithiasis	0.000545	0.00365	CbGpPWpGaD
Dexamethasone—ABCC2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000541	0.00363	CbGpPWpGaD
Dexamethasone—ABCC2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000541	0.00363	CbGpPWpGaD
Dexamethasone—NOS2—Disease—ATP6V0A4—nephrolithiasis	0.000524	0.00351	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—GRHPR—nephrolithiasis	0.00051	0.00341	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—APRT—nephrolithiasis	0.000504	0.00338	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—SLC26A1—nephrolithiasis	0.000504	0.00338	CbGpPWpGaD
Dexamethasone—ABCC2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000503	0.00337	CbGpPWpGaD
Dexamethasone—ABCC2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000503	0.00337	CbGpPWpGaD
Dexamethasone—SLCO1A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000493	0.0033	CbGpPWpGaD
Dexamethasone—SLCO1A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000493	0.0033	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000487	0.00326	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—DGKH—nephrolithiasis	0.000487	0.00326	CbGpPWpGaD
Dexamethasone—ABCG2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000471	0.00315	CbGpPWpGaD
Dexamethasone—ABCG2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000471	0.00315	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—GRHPR—nephrolithiasis	0.000466	0.00312	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—ADCY10—nephrolithiasis	0.000463	0.0031	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—GRHPR—nephrolithiasis	0.000461	0.00309	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—AQP1—nephrolithiasis	0.000457	0.00306	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—AGXT—nephrolithiasis	0.000454	0.00304	CbGpPWpGaD
Dexamethasone—ABCC2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000449	0.003	CbGpPWpGaD
Dexamethasone—ABCC2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000449	0.003	CbGpPWpGaD
Dexamethasone—ABCG2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000438	0.00293	CbGpPWpGaD
Dexamethasone—ABCG2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000438	0.00293	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—AGXT—nephrolithiasis	0.000415	0.00278	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—CHRM3—nephrolithiasis	0.000413	0.00276	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000412	0.00276	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000412	0.00276	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—AGXT—nephrolithiasis	0.000411	0.00275	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—GRHPR—nephrolithiasis	0.000409	0.00274	CbGpPWpGaD
Dexamethasone—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000399	0.00267	CbGpPWpGaD
Dexamethasone—SLCO1A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000394	0.00264	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—RGS14—nephrolithiasis	0.000394	0.00264	CbGpPWpGaD
Dexamethasone—ABCG2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00039	0.00261	CbGpPWpGaD
Dexamethasone—ABCG2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00039	0.00261	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—APRT—nephrolithiasis	0.000386	0.00259	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—SLC26A1—nephrolithiasis	0.000386	0.00259	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000367	0.00246	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—AGXT—nephrolithiasis	0.000365	0.00244	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—AQP1—nephrolithiasis	0.000359	0.00241	CbGpPWpGaD
Dexamethasone—ABCC2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000359	0.0024	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—APRT—nephrolithiasis	0.000353	0.00237	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—SLC26A1—nephrolithiasis	0.000353	0.00237	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CHRM3—nephrolithiasis	0.000352	0.00236	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—SLC26A1—nephrolithiasis	0.00035	0.00234	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—APRT—nephrolithiasis	0.00035	0.00234	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—GRHPR—nephrolithiasis	0.000342	0.00229	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000336	0.00225	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000336	0.00225	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—CHRM3—nephrolithiasis	0.000325	0.00218	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—PTH—nephrolithiasis	0.000322	0.00215	CbGpPWpGaD
Dexamethasone—ABCG2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000312	0.00209	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—SLC26A1—nephrolithiasis	0.00031	0.00208	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—APRT—nephrolithiasis	0.00031	0.00208	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—GRHPR—nephrolithiasis	0.000309	0.00207	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—AGXT—nephrolithiasis	0.000304	0.00204	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—GRHPR—nephrolithiasis	0.000297	0.00199	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—AQP1—nephrolithiasis	0.000275	0.00184	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—AGXT—nephrolithiasis	0.000275	0.00184	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—GRHPR—nephrolithiasis	0.00027	0.00181	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—GRHPR—nephrolithiasis	0.000268	0.0018	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—DGKH—nephrolithiasis	0.000266	0.00178	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000266	0.00178	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—AGXT—nephrolithiasis	0.000265	0.00177	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—APRT—nephrolithiasis	0.000259	0.00173	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—SLC26A1—nephrolithiasis	0.000259	0.00173	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000255	0.0017	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000255	0.0017	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—AQP1—nephrolithiasis	0.000252	0.00169	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—AQP1—nephrolithiasis	0.000249	0.00167	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—CHRM3—nephrolithiasis	0.000249	0.00167	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—GRHPR—nephrolithiasis	0.000246	0.00165	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—AGXT—nephrolithiasis	0.000241	0.00161	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—AGXT—nephrolithiasis	0.000239	0.0016	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000237	0.00158	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000237	0.00158	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—SLC26A1—nephrolithiasis	0.000234	0.00157	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—APRT—nephrolithiasis	0.000234	0.00157	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—CHRM3—nephrolithiasis	0.000228	0.00152	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—SLC26A1—nephrolithiasis	0.000225	0.00151	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—APRT—nephrolithiasis	0.000225	0.00151	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—CHRM3—nephrolithiasis	0.000225	0.00151	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—AQP1—nephrolithiasis	0.000221	0.00148	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—AGXT—nephrolithiasis	0.000219	0.00147	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000211	0.00141	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000211	0.00141	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—GRHPR—nephrolithiasis	0.000206	0.00138	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—SLC26A1—nephrolithiasis	0.000205	0.00137	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—APRT—nephrolithiasis	0.000205	0.00137	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—SLC26A1—nephrolithiasis	0.000203	0.00136	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—APRT—nephrolithiasis	0.000203	0.00136	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—CHRM3—nephrolithiasis	0.0002	0.00134	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—GRHPR—nephrolithiasis	0.000198	0.00133	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—GRHPR—nephrolithiasis	0.000194	0.0013	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—GRHPR—nephrolithiasis	0.000194	0.0013	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CHRM3—nephrolithiasis	0.000192	0.00129	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—SLC26A1—nephrolithiasis	0.000187	0.00125	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—APRT—nephrolithiasis	0.000186	0.00125	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—SLC26A1—nephrolithiasis	0.000186	0.00125	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—AQP1—nephrolithiasis	0.000184	0.00124	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—AGXT—nephrolithiasis	0.000184	0.00123	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—GRHPR—nephrolithiasis	0.000183	0.00123	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—AGXT—nephrolithiasis	0.000177	0.00118	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—PTH—nephrolithiasis	0.000176	0.00118	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—AGXT—nephrolithiasis	0.000173	0.00116	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—AGXT—nephrolithiasis	0.000173	0.00116	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000169	0.00113	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—GRHPR—nephrolithiasis	0.000168	0.00112	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—CHRM3—nephrolithiasis	0.000167	0.00112	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—AQP1—nephrolithiasis	0.000167	0.00112	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—ATP6V0A4—nephrolithiasis	0.000166	0.00111	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—AGXT—nephrolithiasis	0.000163	0.00109	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—SPP1—nephrolithiasis	0.000162	0.00108	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—AQP1—nephrolithiasis	0.000161	0.00108	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—APRT—nephrolithiasis	0.000156	0.00105	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—SLC26A1—nephrolithiasis	0.000156	0.00105	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—CHRM3—nephrolithiasis	0.000151	0.00101	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—SLC26A1—nephrolithiasis	0.00015	0.00101	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—APRT—nephrolithiasis	0.00015	0.00101	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—GRHPR—nephrolithiasis	0.00015	0.001	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—AGXT—nephrolithiasis	0.00015	0.001	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—SLC26A1—nephrolithiasis	0.000147	0.000986	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—APRT—nephrolithiasis	0.000147	0.000986	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—SLC26A1—nephrolithiasis	0.000147	0.000984	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—APRT—nephrolithiasis	0.000147	0.000984	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000146	0.000979	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—AQP1—nephrolithiasis	0.000146	0.000978	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—CHRM3—nephrolithiasis	0.000145	0.000972	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—AQP1—nephrolithiasis	0.000145	0.000969	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—SLC26A1—nephrolithiasis	0.000139	0.000929	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—APRT—nephrolithiasis	0.000139	0.000929	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000138	0.000923	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GRHPR—nephrolithiasis	0.000137	0.000915	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—AGXT—nephrolithiasis	0.000134	0.000894	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—AQP1—nephrolithiasis	0.000133	0.000889	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—CHRM3—nephrolithiasis	0.000132	0.000885	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—CHRM3—nephrolithiasis	0.000131	0.000877	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—AGXT—nephrolithiasis	0.00013	0.000873	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—APRT—nephrolithiasis	0.000127	0.000852	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—SLC26A1—nephrolithiasis	0.000127	0.000852	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000123	0.000823	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—AGXT—nephrolithiasis	0.000122	0.000815	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—CHRM3—nephrolithiasis	0.00012	0.000804	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—APRT—nephrolithiasis	0.000114	0.00076	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—SLC26A1—nephrolithiasis	0.000114	0.00076	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—AQP1—nephrolithiasis	0.000111	0.000746	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.000111	0.000742	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—APRT—nephrolithiasis	0.000111	0.000742	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—AQP1—nephrolithiasis	0.000107	0.000717	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—AQP1—nephrolithiasis	0.000105	0.000702	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—AQP1—nephrolithiasis	0.000105	0.000701	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000104	0.000699	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000104	0.000699	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—APRT—nephrolithiasis	0.000104	0.000693	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	0.000104	0.000693	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—CHRM3—nephrolithiasis	0.000101	0.000675	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—AQP1—nephrolithiasis	9.89e-05	0.000662	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—CHRM3—nephrolithiasis	9.68e-05	0.000648	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—CHRM3—nephrolithiasis	9.48e-05	0.000635	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—CHRM3—nephrolithiasis	9.46e-05	0.000634	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—AQP1—nephrolithiasis	9.06e-05	0.000607	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GRHPR—nephrolithiasis	9.01e-05	0.000603	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—CHRM3—nephrolithiasis	8.94e-05	0.000599	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—SPP1—nephrolithiasis	8.83e-05	0.000591	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—CHRM3—nephrolithiasis	8.2e-05	0.000549	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—AQP1—nephrolithiasis	8.09e-05	0.000542	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—AGXT—nephrolithiasis	8.03e-05	0.000538	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—AQP1—nephrolithiasis	7.9e-05	0.000529	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—AQP1—nephrolithiasis	7.44e-05	0.000498	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—AQP1—nephrolithiasis	7.38e-05	0.000494	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CHRM3—nephrolithiasis	7.32e-05	0.00049	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CHRM3—nephrolithiasis	7.14e-05	0.000478	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	6.83e-05	0.000457	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—APRT—nephrolithiasis	6.83e-05	0.000457	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CHRM3—nephrolithiasis	6.73e-05	0.000451	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CHRM3—nephrolithiasis	6.67e-05	0.000447	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—AQP1—nephrolithiasis	4.87e-05	0.000326	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CHRM3—nephrolithiasis	4.4e-05	0.000295	CbGpPWpGaD
